ASNC 2017

Sep 14, 2017 ‐ Sep 17, 2017



Sessions

Opening Plenary and Verani Lecture

Sep 15, 2017 7:45am ‐ Sep 15, 2017 9:30am

Identification: 201

Moderators: Donna M. Polk, MD, MPH, FASNC

Learning Objectives:

  • Learn new directions in cardiac imaging in order to anticipate future needs

07:45 - 07:55 - Opening Remarks from the ASNC CEO
Kathleen Flood

07:55 - 08:05 - Remarks from ASNC2017 Program Chair
Donna M. Polk, MD, MPH, FASNC

08:05 - 08:20 - President's Address
Raymond R. Russell, MD, PhD, FASNC

08:20 - 08:25 - ASNC & ASE: Innovation Collaboration
Vera H. Rigolan, MD

08:25 - 08:45 - President Elect's Address
Prem Soman, MD, PhD, FASNC

08:45 - 08:50 - Presentation of Kenneth Brown Award
Ami E. Iskandrian, MD, PhD, MASNC

08:50 - 08:55 - Introduction of Verani Lecturer
Raymond R. Russell, MD, PhD, FASNC

08:55 - 09:30 - Evolving, Innovating and Revolutionary Changes in Cardiovascular Imaging - We Have Only Begun
Leslee J. Shaw, PhD, MASNC

Moderator(s): Speaker(s):

Nuclear Cardiology Laboratory in 2017

Sep 15, 2017 10:30am ‐ Sep 15, 2017 12:00pm

Identification: 206

Moderators: David E. Winchester, MD, FASNC; Thomas A. Holly, MD, FASNC

Learning Objectives:

  • Understand basic overview of attenuation correction, the potential pitfalls and how to optimise practice
  • Attendees will learn sources of radiation in Cardiac PET, SPECT and CT
  • Attendees will review the principles of ALARA and how to apply them to diagnostic testing
  • Attendees will learn practical strategies for reducing patient and staff radiation dose based on nationally and internationally recognized standards

10:30 - 10:45 - ImageGuide: How it can Improve Your Practice
Nishant Shah, MD, MPH

10:45 - 11:00 - ALARA: Practical Approaches to Radiation Reduction
James A. Case, PhD

11:00 - 11:15 - Lab Accreditation: Nuts and Bolts
Eric V. Burgett, CNMT, NCT

11:15 - 11:30 - Optimizing Attenuation Correction and Reconstruction
Parthiban Arumugam, MB, BS

11:30 - 11:45 - Advances in Nuclear Camera Technology
Ernest V. Garcia, PhD, MASNC

11:45 - 12:00 - Discussion

Moderator(s): Speaker(s):

Multimodality Imaging in the Diagnosis and Management of Heart Failure

Sep 15, 2017 1:30pm ‐ Sep 15, 2017 3:00pm

Identification: 215

Moderators: James E. Udelson, MD, MASNC; Mary N. Walsh, MD, FASNC

Learning Objectives:

  • Understand how nuclear cardiology techniques can be used to assess for myocardial inflammation
  • Highlight importance of viability imaging in ischemic heart failure
  • Examine long term follow in STICH trial and PARR-2 study
  • Consider other applications of nuclear cardiology to risk stratify patients with ischemia heart failure

13:30 - 13:50 - How Does Imaging Guide Contemporary Management of the Heart Failure Patient?
Mary N. Walsh, MD, FASNC

13:50 - 14:05 - Evaluation of Ischemia and Viability in Heart Failure/LV Dysfunction: Is it Still Relevant?
Gary R. Small, MD

14:05 - 14:20 - Novel Approaches to Evaluate Myocardial Inflammatory Diseases
Ron Blankstein,MD, FASNC

14:20 - 14:35 - The Rapidly Emerging Role of Multimodality Imaging to Diagnose and Manage the Cardiac Amyloidoses
Frederick L. Ruberg, MD

14:35 - 14:50 - Patient Perspective: Experiencing a Heart Transplant (An Interview)
Rory Hachamovitch, MD, FASNC

Moderator(s): Speaker(s):

How to Establish a Cardiac PET Program

Sep 15, 2017 4:00pm ‐ Sep 15, 2017 5:30pm

Identification: 222

Moderators: Erick Alexanderson, MD; Raymond R. Russell, MD, PhD, FASNC

Learning Objectives:

  • Appreciate improvements to patient flow in a dedicated cardiac PET program

16:00 - 16:20 - Which Business Model is Right for my Practice 
Timothy M. Bateman, MD, MASNC

16:20 - 16:40 - Start-up Considerations and Patient Selection for Cardiac PET
Mouaz H. Al-Mallah, MD, FASNC

16:40 - 17:00 - Workflow Strategies in a Cardiac PET Program
Ritesh Dhar, MD

17:00 - 17:20 - PET Perfusion Tracers: Which one to Choose for Which Model
Gary V. Heller, MD, PhD, MASNC

17:20 - 17:30 - Discussion

Moderator(s): Speaker(s):

The Emerging Clinical Challenge of Symptomatic Non-obstructive Coronary Artery Disease

Sep 16, 2017 8:00am ‐ Sep 16, 2017 9:30am

Identification: 301

Moderators: John Well Askew, MD, FASNC; Dr. Randall C. Thompson, MD, FASNC

Learning Objectives:

  • To review the causes of discordant findings on myocardial perfusion imaging and coronary angiography
  • Understand the associations of non-obstructive CAD with subsequent cardiac events, the plaque features that are most predictive of high risk, and the use of serial assessments

08:00 - 08:20 - Nomenclature: Syndrome X, Microvascular Angina, Coronary Microvascular Dysfunction - One and the Same?
Leslee J. Shaw, PhD, MASNC

08:20 - 08:40 - Is this the Sweet Spot for Coronary CT?
Daniel S. Berman, MD, MASNC

08:40 - 09:00 - The Challenge with Stress Testing: How to Differentiate Microvascular Disease from a False Positive Test
Raymond J. Gibbons, MD, MASNC

09:00 - 09:20 - Can Imaging Help Guide Management?
Viviany R. Taqueti, MD

09:20 - 09:30 - Discussion

Moderator(s): Speaker(s):

Cardiac Amyloidosis in 2017Cardiac Amyloidosis in 2017

Preview Available

Cardiac Amyloidosis in 2017

Sep 16, 2017 10:30am ‐ Sep 16, 2017 12:00pm

Identification: 305

Moderators: Mylan C. Cohen, MD, MPH, MASNC; Paul Cremer, MD

Learning Objectives:

  • Understand the complementary role of echocardiography and cardiac magnetic resonance imaging for the diagnostic and prognostic evaluation of patients with cardiac amyloidosis

10:30 - 10:50 - Pathogenesis of Amyloidosis
Kevin M. Alexander, MD

10:50 - 11:10 - What's New and What's on the Horizon in Diagnosis and Treatment
Frederick L. Ruberg, MD

11:10 - 11:30 - Echocardiography and MRI in Amyloidosis
Edward Hulten, MD, MPH, FASNC

11:30 - 11:50 - Common and Uncommon Findings of PYP Imaging with Cases
Sabahat Bokhari, MD, FASNC

11:50 - 12:00 - Discussion

Moderator(s): Speaker(s):

Debate: Clash of the TitansDebate: Clash of the Titans

Preview Available

Debate: Clash of the Titans

Sep 16, 2017 1:30pm ‐ Sep 16, 2017 3:00pm

Identification: 315

Moderators: Lawrence M. Phillips, MD, FASNC; L. Samuel Wann, MD

Learning Objectives:

  • Recognize the utility of FFR guided revascularization
  • Understand that in 4000 sequential cardiac PETs, the Coronary Flow Capacity combining stress perfusion and CFR uniquely identifies patients for whom PCI/CABG significantly reduces MI and mortality by 54% over long term follow up and eliminates 70% to 90% of low benefit invasive procedures or other tests including patients with known or advanced CAD with low risk disease by PET that are optimally treated medically
  • Understand the mechanisms that can produce mis-registration between CT attenuation and PET emission images and cause artifacts

13:30 - 13:40 - Is Solid State SPECT a Viable Substitute for PET Imaging? Pro
Prem Soman, MD, PhD, FASNC

13:40 - 13:50 - Is Solid State SPECT a Viable Substitute for PET Imaging? Con
Terrence D. Ruddy, MD

13:50 - 14:00 - Rebuttals

14:00 - 14:10 - Is CT-FFR Assessment Offlow Physiology Comparable to PET? Pro
Benjamin Chow, MD, FASNC

14:10 - 14:20 - Is CT-FFR Assessment Offlow Physiology Comparable to PET? Con
K. Lance Gould, MD

14:20 - 14:30 - Rebuttals

14:30 - 14:40 - Is CT Attenuation Correction the Best Option for PET Imaging? Pro
Marcelo Di Carli, MD

14:40 - 14:50 - Is CT Attenuation Correction the Best Option for PET Imaging? Con
Nils P. Johnson, MD

14:50 - 15:00 - Rebuttals

Moderator(s): Speaker(s):

Controversies in Clinical Cardiology and Cardiac Imaging

Sep 17, 2017 8:00am ‐ Sep 17, 2017 9:30am

Identification: 401

Moderator: Prem Soman, MD, PhD, FASNC; Viviany R. Taqueti, MD

Learning Objectives:

  • Understand that in 4000 sequential cardiac PETs, the Coronary Flow Capacity combining stress perfusion and CFR uniquely identifies patients for whom PCI/CABG significantly reduces MI and mortality by 54% over long term follow up and eliminates 70% to 90% of low benefit invasive procedures or other tests including patients with known or advanced CAD with low risk disease by PET that are optimally treated medically
  • To become familiar with the etiology of LV ejection fraction decline in patients receiving cardiotoxic chemotherapy

08:00 - 08:12 - Debate 1 - Breakthrough: Novel approaches for Early Detection of Chemotherapy Cardiotoxicity
W. Gregory Hundley, MD

08:12 - 08:24 - Debate 1 - Controversy: What Would it take for Novel Markers of Cardiac Toxicity to Replace Ejection Fraction
Indu Poornima, MD

08:24 - 08:30 - Discussion

08:30 - 08:42 - Debate 2 - Breakthrough: FDG Imaging of Cardiac and Vascular Inflammation
Ahmed Tawakol, MD

08:42 - 08:54 - Debate 2 - Controversy: Is FDG Imaging the Be-all and End-all?
Robert J. Gropler, MD, MASNC

08:54 - 09:00 - Discussion

09:00 - 09:12 - Debate 3 - Breakthrough: Noninvasive Quantification of Coronary Flow Reserve
Marcelo Di Carli, MD

09:12 - 09:24 - Debate 3 - Controversy: Is Coronary Flow Reserve Good Enough to Guide Management in CAD?
K. Lance Gould, MD

09:24 - 09:30 - Discussion

Moderator(s): Speaker(s):

Approach to Known or Potential Ischemic Heart Disease

Sep 17, 2017 9:45am ‐ Sep 17, 2017 10:45am

Identification: 402

Moderator: Justin B. Lundbye, MD, FASNC; Mark I. Travin, MD, FASNC

Learning Objectives:

  • Understand when no imaging studies are required to assess chest pain
  • Identify recent advances in the use of nuclear imaging and electrogram guidance to distinguish specific causes of cardiomyopathy
  • After successful completion of this activity, participants should be able to‚ĶUnderstand the recent progress made in radiotracer-based evaluation of peripheral arterial disease.
  • Understand the recent progress made in radiotracer-based evaluation of peripheral arterial disease.

09:45 - 10:00 - Which Imaging Test to Begin with in the Context of Varying Guidelines

Manuel D. Cerqueira, MD, MASNC

10:00 - 10:15 - Benefits of Myocardial Blood Flow Quantitation (with Attention to Microvascular Disease, Especially in Women)
Venkatesh L. Murthy, MD, PhD

10:15 - 10:30 - Imaging Plaque: how do we do it?
Mehran Sadeghi, MD

10:30 - 10:45 - Radionuclide Imaging of Peripheral Arterial Disease
Mitchel R. Stacy, PhD

Moderator(s): Speaker(s):

How Does Radionuclide Imaging Guide Clinical Decision Making?

Sep 17, 2017 11:00am ‐ Sep 17, 2017 12:00pm

Identification: 404

Moderator: Christopher L. Hansen, MD, FASNC; Hicham Skali, MD

Learning Objectives:

  • Be aware of the appropriate and rarely appropriate use of nuclear cardiology stress testing

11:00 - 11:20 - How to Decide When to Proceed to Angiography
Hicham Skali, MD

11:20 - 11:40 - Latest in Viability Assessment
Jamshid Maddahi, MD, FASNC

11:40 - 12:00 - Preoperative Testing: When is Preoperative Evaluation Helpful
Todd D. Miller, MD

Moderator(s): Speaker(s):